Future of Pharmaceuticals

Sarfaraz K. Niazi, Ph.D., is an Adjunct Professor at the University of Illinois and University of Houston; he has authored 60+ major books, 100+ research papers, and 100+ patents, mainly in the field of bioprocessing, drug discovery, mRNA vaccines, drug formulations, thermodynamic systems, alcohol aging, nutraceuticals and treatment of autoimmune diseases. He has established multiple biotechnology projects, from concept to market. He also serves as an advisor to major pharmaceutical and biopharmaceutical companies, regulatory agencies, the FDA, the US Congress, and several heads of state. He is also a patent law practitioner.

Select Guide Rating

• Preface.....................................................................................................................................................xixAcknowledgments.................................................................................................................................xxviiAuthor....................................................................................................................................................xxixGlossary of Important Terminology......................................................................................................xxxi1 Understanding Nonlinearity............................................................................................................ 12 The Evolution of Pharmaceuticals................................................................................................. 233 Artificial Intelligence...................................................................................................................... 694 Drug Discovery Trends................................................................................................................... 915 Drug Development Assays.............................................................................................................1436 Nanomedicine................................................................................................................................ 1957 Antimicrobials................................................................................................................................2318 Therapeutic Proteins......................................................................................................................2519 Manufacturing Trends................................................................................................................. 30710 Therapeutic Protein Delivery Systems........................................................................................ 34511 Gene and Cell Therapy..................................................................................................................38112 Nucleic Acid Vaccines....................................................................................................................42113 Botanical Products........................................................................................................................ 43914 Regulatory Optimization.............................................................................................................. 46915 Intellectual Property......................................................................................................................531Index........................................................................................................................................................557